Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advancing HIV Broadly Neutralizing Antibodies: From Discovery to the Clinic
David A. Spencer, Mariya B. Shapiro, Nancy L. Haigwood, et al.
Frontiers in Public Health (2021) Vol. 9
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy
Kristian Daniel Ralph Roth, Esther Veronika Wenzel, Maximilian Ruschig, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 58
Broadly neutralizing monoclonal antibodies for HIV prevention
Maurine D. Miner, Lawrence Corey, David C. Montefiori
Journal of the International AIDS Society (2021) Vol. 24, Iss. S7
Open Access | Times Cited: 34
Phagocytosis by an HIV antibody is associated with reduced viremia irrespective of enhanced complement lysis
David A. Spencer, Benjamin S. Goldberg, Shilpi Pandey, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 25
Recent Progress in the Discovery and Development of Monoclonal Antibodies against Viral Infections
Pardis Mokhtary, Zeinab Pourhashem, Akram Abouei Mehrizi, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1861-1861
Open Access | Times Cited: 23
Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention
Sharana Mahomed, Nigel Garrett, Edmund V. Capparelli, et al.
The Journal of Infectious Diseases (2022) Vol. 226, Iss. 3, pp. 510-520
Open Access | Times Cited: 21
Advancing the prevention and treatment of HIV in children: priorities for research and development
Martina Penazzato, Claire L Townsend, Nadia A. Sam‐Agudu, et al.
The Lancet HIV (2022) Vol. 9, Iss. 9, pp. e658-e666
Closed Access | Times Cited: 21
Uses and Challenges of Antiviral Polyclonal and Monoclonal Antibody Therapies
Evi Struble, Jonathan Rawson, Tzanko S. Stantchev, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1538-1538
Open Access | Times Cited: 13
Applying Flow Virometry to Study the HIV Envelope Glycoprotein and Differences Across HIV Model Systems
Jonathan Burnie, Claire Fernandes, Ayushi Patel, et al.
Viruses (2024) Vol. 16, Iss. 6, pp. 935-935
Open Access | Times Cited: 3
Update on HIV Chemoprevention
Cheríe Blair, Mary Catherine Cambou, Raphael J. Landovitz
Annual Review of Medicine (2025) Vol. 76, Iss. 1, pp. 43-56
Closed Access
The Fight Continues: Virus Without Vaccines
Van G. Wilson
(2025), pp. 373-391
Closed Access
Clinical trials of broadly neutralizing monoclonal antibodies in people living with HIV – a review
Sharana Mahomed, Komala Pillay, Razia Hassan-Moosa, et al.
AIDS Research and Therapy (2025) Vol. 22, Iss. 1
Open Access
Vaccinal effect of HIV-1 antibody therapy: dream or reality?
Mar Naranjo‐Gómez, Mireia Pelegrín
Current Opinion in HIV and AIDS (2023) Vol. 18, Iss. 4, pp. 209-216
Closed Access | Times Cited: 9
Caregivers of children with HIV in Botswana prefer monthly IV Broadly Neutralizing Antibodies (bNAbs) to daily oral ART
Maureen Sakoi, Gbolahan Ajibola, Roxanna Haghighat, et al.
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0299942-e0299942
Open Access | Times Cited: 2
Partial compartmentalisation of HIV-1 subtype C between lymph nodes, peripheral blood mononuclear cells and plasma
Neschika Jeewanraj, Tawanda Mandizvo, Takalani Mulaudzi, et al.
Virology (2023) Vol. 582, pp. 62-70
Open Access | Times Cited: 6
Challenges and Opportunities of Therapies Targeting Early Life Immunity for Pediatric HIV Cure
Stella J. Berendam, Ashley N. Nelson, Bhrugu Yagnik, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Clinical trials aimed at HIV cure or remission: new pathways and lessons learned
Maya Dyveke Schou, Ole S. Søgaard, Thomas A. Rasmussen
Expert Review of Anti-infective Therapy (2023) Vol. 21, Iss. 11, pp. 1227-1243
Closed Access | Times Cited: 5
Susceptibility to 3BNC117 and 10-1074 in ART suppressed chronically infected persons
Pablo Tebas, Kenn Lynn, Livio Azzoni, et al.
AIDS (2023)
Closed Access | Times Cited: 4
More than the Infinite Monkey Theorem: NHP Models in the Development of a Pediatric HIV Cure
Jairo A. Fonseca, Alexis C. King, Ann Chahroudi
Current HIV/AIDS Reports (2024) Vol. 21, Iss. 1, pp. 11-29
Open Access | Times Cited: 1
Design of human immunodeficiency virus-1 neutralizing peptides targeting CD4-binding site: An integrative computational biologics approach
Sandhya Vivekanandan, Umashankar Vetrivel, Luke Elizabeth Hanna
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 6
HIV cure: an acceptability scientific agenda
Evelyn Yayra Bonney, Helena Lamptey, George B. Kyei
Current Opinion in HIV and AIDS (2022) Vol. 18, Iss. 1, pp. 12-17
Open Access | Times Cited: 5
Post-Immune Antibodies in HIV-1 Infection in the Context of Vaccine Development: A Variety of Biological Functions and Catalytic Activities
Anna M. Timofeeva, Sergey E. Sedykh, Georgy A. Nevinsky
Vaccines (2022) Vol. 10, Iss. 3, pp. 384-384
Open Access | Times Cited: 4
Subtle Longitudinal Alterations in Env Sequence Potentiate Differences in Sensitivity to Broadly Neutralizing Antibodies following Acute HIV-1 Subtype C Infection
Tawanda Mandizvo, Nombali Gumede, Bongiwe Ndlovu, et al.
Journal of Virology (2022) Vol. 96, Iss. 24
Open Access | Times Cited: 4
A potential antibody repertoire diversification mechanism through tyrosine sulfation for biotherapeutics engineering and production
Xiaotian Zhong, Aaron M. D’Antona
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 4
Computational Characterization of the Binding Properties of the HIV1-Neutralizing Antibody PG16 and Design of PG16-Derived CDRH3 Peptides
Manuel Deubler, Lucas Weißenborn, Simon Leukel, et al.
Biology (2023) Vol. 12, Iss. 6, pp. 824-824
Open Access | Times Cited: 2
Predicted resistance to broadly neutralizing antibodies (bnAbs) and associated HIV-1 envelope characteristics among seroconverting adults in Botswana
Natasha O. Moraka, Wonderful T. Choga, Marea N. Pema, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top